Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication – Case ReportSuccessful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication – Case Report
|
| 0 Comment
In sufferers with compromised immune operate, extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) an infection and coronavirus illness 2019 (CoVID-19) impose specific challenges. Particularly in hematological malignancies, together with lymphoma,